aprevo® posterior/transforaminal lumbar interbody fusion device
K-Number: K250987 · 2025-06-30
Device Summary
Frequently Asked Questions
What is the aprevo® posterior/transforaminal lumbar interbody fusion device?
aprevo® posterior/transforaminal lumbar interbody fusion device is a medical device that received FDA 510(k) clearance on 2025-06-30. The listed applicant is Carlsmed, Inc.. The 510(k) number is K250987.
When did aprevo® posterior/transforaminal lumbar interbody fusion device receive FDA 510(k) clearance?
aprevo® posterior/transforaminal lumbar interbody fusion device received FDA 510(k) clearance on 2025-06-30, under 510(k) number K250987.
Who is the listed applicant for aprevo® posterior/transforaminal lumbar interbody fusion device?
The FDA 510(k) record lists Carlsmed, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for aprevo® posterior/transforaminal lumbar interbody fusion device?
The FDA product code for aprevo® posterior/transforaminal lumbar interbody fusion device is MAX.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related PubMed Literature
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Carlsmed, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: MAX)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.